AlphAIAlphAI — Financial news for AI agents
gurufocus.comOCT 72 min read$NVMI

Nova Ltd (NVMI) Shares Fall 4.2% -- GF Value Says Still Overvalu

Nova Ltd (NVMI) shares fell 4.2% to $377.77, trading 11.2% above GF Value's estimate of $339.86, indicating overvaluation. NVMI has a GF Score of 95/100, with strong profitability and growth but concerns over valuation. Insiders sold $6.7M in shares over the past year.

Original reporting
gurufocus.com
Published Oct 7, 2026, 10:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 10:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMarket movers
Primary signal
$NVMI
Bearish
medium confidence
Mentioned
$NVMI
Relevance
4/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$NVMIBearishLow
01

Why it matters

The overvaluation signal and insider selling may prompt short positions or profit-taking.

02

Market read

The article provides a valuation perspective that may influence short-term trading decisions on NVMI.

03

What to watch

Potential upcoming product launches or market catalysts not covered in the article could offset valuation concerns.

Relevance 4/10Novelty 2/10Timing: today

Background

GuruFocus valuation analysis reports Nova Ltd (NVMI) trading above its intrinsic estimate with a strong GF Score but elevated P/E.

Company-level read

Ticker impact

$NVMIBearishMedium confidence
Context

NVMI shares fell 4.2% to $377.77 and are deemed 11.2% over its GF Value estimate, indicating overvaluation and recent insider selling.

Expected impact

downward pressure as investors price in overvaluation concerns

Evidence & confidence

Overvaluation relative to GF Value and recent insider sales suggest limited upside and potential further declines.

Market effects

Sector

Valuation concerns may affect peer biotech/tech stocks with similar high P/E ratios.

Regional

Limited to US-listed investors tracking Nova Ltd.

Global

Minimal global impact.

Counterpoint

What could challenge this read

Some investors may view the high GF Score and growth metrics as justification for holding despite overvaluation.

Key entities

  • company
    Nova Ltd

    US-listed company (ticker NVMI) subject of valuation analysis.

Read at source← All news

Related articles

SEP 7
$NVMIMedAI 8/10

Nova (NVMI) Just Blew Past $250M In Quarterly Sales

Nova (NVMI) reported Q2 2026 revenue of $255M, up 8% QoQ and 16% YoY, with GAAP net income of $75M and non-GAAP net income of $86.5M. GAAP EPS was $2.20, up from $2.04 QoQ and $2.14 YoY. Non-GAAP EPS was $2.51, up from $2.33 QoQ and $2.20 YoY. The company guided Q3 2026 revenue to $277M-$287M, GAAP EPS to $2.46-$2.61, and non-GAAP EPS to $2.70-$2.85. Gross margin declined to 56.5% from 57.7% QoQ and 57.8% YoY.

yahoo.com2 min
SEP 1
$ESLTMed

Tue: Rate cut lifts market

The Tel Aviv Stock Exchange rose after the Bank of Israel cut interest rates to 3.25%. The Tel Aviv 35 Index gained 0.22%, while Dimri led gains with a 5.47% rise. OPC Energy fell 4.67%, the biggest decline. Key movers included Elbit Systems, Teva, and Ormat, which rose, and Camtek and Tower Semiconductor, which fell.

en.globes.co.il2 min
AUG 6
$NVMIHigh

NOVA LTD. (NVMI): Financial results for Q2 2026

NOVA LTD. (NVMI) furnished an SEC Form 6-K — earnings release. Attached hereto and incorporated by way of reference herein is a press release issued by the Registrant and entitled: “Nova Reports Record Second Quarter 2026 Financial Results”. The GAAP financial statements tables included in the press release attached hereto are hereby incorpo

SEC EDGAR 6-K2 min